{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T15:53:08Z","timestamp":1732031588471},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1007\/s00347-004-1166-2","type":"journal-article","created":{"date-parts":[[2005,1,24]],"date-time":"2005-01-24T03:01:15Z","timestamp":1106535675000},"page":"329-334","source":"Crossref","is-referenced-by-count":21,"title":["Morbus Adamantiades-Beh\ufffdet"],"prefix":"10.1007","volume":"102","author":[{"given":"L.","family":"Krause","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"271","volume":"168","author":"Adamantiades","year":"1931","unstructured":"Adamantiades B (1931) Sur un cas d \u00edritis hypopyon recidivant. Ann Oculist 168:271?278","journal-title":"Ann Oculist"},{"key":"CR2","first-page":"S40","volume":"20","author":"Adler","year":"2002","unstructured":"Adler YD, Jovanovic S, Jivanjee A, Krause L, Zouboulis CC (2002) Adamantiades-Behcet?s disease with inner ear involvement. Clin Exp Rheumatol 20 [4 Suppl 26]:S40?42","journal-title":"Clin Exp Rheumatol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0190-9622(94)70226-8","volume":"31","author":"Alpsoy","year":"1994","unstructured":"Alpsoy E, Yilmaz E, Basaran E (1994) Interferon therapy for Behcet?s disease. J Am Acad Dermatol 31 (4):617?619","journal-title":"J Am Acad Dermatol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1046\/j.1365-4362.2003.01893.x","volume":"42","author":"Azizlerli","year":"2003","unstructured":"Azizlerli G, Kose AA, Sarica R et al. (2003) Prevalence of Behcet?s disease in Istanbul, Turkey. Int J Dermatol 42 (10):803?806","journal-title":"Int J Dermatol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3349\/ymj.1997.38.6.401","volume":"38","author":"Bang","year":"1997","unstructured":"Bang D (1997) Treatment of Behcet?s disease. Yonsei Med J 38 (6):401?410","journal-title":"Yonsei Med J"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3346\/jkms.2003.18.2.231","volume":"18","author":"Bang","year":"2003","unstructured":"Bang DS, Oh SH, Lee KH, Lee ES, Lee SN (2003) Influence of sex on patients with Behcet?s disease in Korea. J Korean Med Sci 18 (2):231?235","journal-title":"J Korean Med Sci"},{"key":"CR7","doi-asserted-by":"crossref","unstructured":"Barnes CG, Yazici H (1999) Behcet?s syndrome. Rheumatology (Oxford) 38 (12):1171?1174","DOI":"10.1093\/rheumatology\/38.12.1171"},{"key":"CR8","first-page":"1152","volume":"105","author":"Beh","year":"1937","unstructured":"Beh\u00e7et H (1937) \u00dcber rezidivierende, apht\u00f6se, durch ein Virus verursachte Geschw\u00fcre im Mund, am Auge und an den Genitalien. Dermatol Wochenschr 105:1152?1157","journal-title":"Dermatol Wochenschr"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/ard.43.1.70","volume":"43","author":"Davies","year":"1984","unstructured":"Davies PG, Fordham JN, Kirwan JR, Barnes CG, Dinning WJ (1984) The pathergy test and Behcet?s syndrome in Britain. Ann Rheum Dis 43 (1):70?73","journal-title":"Ann Rheum Dis"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/art.1780400425","volume":"40","author":"Hamuryudan","year":"1997","unstructured":"Hamuryudan V, Ozyazgan Y, Hizli N et al. (1997) Azathioprine in Behcet?s syndrome: effects on long-term prognosis. Arthritis Rheum 40 (4):769?774","journal-title":"Arthritis Rheum"},{"key":"CR11","first-page":"928","volume":"4","author":"Hamuryudan","year":"2002","unstructured":"Hamuryudan V, Ozyazgan Y, Fresko Y, Mat C, Yurdakul S, Yazici H (2002) Interferon alfa combined with azathioprine for the uveitis of Behcet?s disease: an open study. Isr Med Assoc J 4 [Suppl 11]:928?930","journal-title":"Isr Med Assoc J"},{"key":"CR12","first-page":"1078","volume":"335","author":"International","year":"1990","unstructured":"International Study Group for Behcet?s Disease (1990) Criteria for diagnosis of Behcet?s disease. Lancet 335 (8697):1078?1080","journal-title":"Lancet"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/bjo.87.4.423","volume":"87","author":"Kotter","year":"2003","unstructured":"Kotter I, Zierhut M, Eckstein AK et al. (2003) Human recombinant interferon alfa-2a for the treatment of Behcet?s disease with sight threatening posterior or panuveitis. Br J Ophthalmol 87 (4):423?431","journal-title":"Br J Ophthalmol"},{"key":"CR14","unstructured":"Krause L (2004) Morbus Adamantiades-Beh\u00e7et. In: Heimann H, Kellner U, Foerster MH (Hrsg) Angiographie-Atlas des Augenhintergrundes. Thieme, Stuttgart New York, S 126?127"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00417-003-0754-1","volume":"241","author":"Krause","year":"2003","unstructured":"Krause L, Hoffmann F, Zouboulis CC, Foerster MH (2003) Vitrectomy and trabeculectomy combined with interferon alpha treatment in Adamantiades-Behcet?s disease: a case report. Graefes Arch Clin Exp Ophthalmol 241 (10):871?874","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/0-306-48382-3_103","volume":"528","author":"Krause","year":"2003","unstructured":"Krause L, Turnbull JR, Torun N, Pleyer U, Zouboulis CC, Foerster MH (2003) Interferon alfa-2a in the treatment of ocular Adamantiades-Behcet?s disease. Adv Exp Med Biol 528:511?519","journal-title":"Adv Exp Med Biol"},{"key":"CR17","first-page":"278","volume":"19","author":"Masuda","year":"1975","unstructured":"Masuda K (1975) A nation-wide survey of Beh\u00e7et?s disease in Japan. Jpn J Ophthalmol 19:278?285","journal-title":"Jpn J Ophthalmol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1034\/j.1600-0420.2001.079002192.x","volume":"79","author":"Ozerturk","year":"2001","unstructured":"Ozerturk Y, Bardak Y, Durmus M (2001) Vitreoretinal surgery in Behcet?s disease with severe ocular complications. Acta Ophthalmol Scand 79 (2):192?196","journal-title":"Acta Ophthalmol Scand"},{"key":"CR19","first-page":"CD001084","volume":"2000","author":"Saenz","year":"2002","unstructured":"Saenz A, Ausejo M, Shea B, Wells G, Welch V, Tugwell P (2002) Pharmacotherapy for Behcet?s syndrome. Cochrane Database Syst Rev 2000 (2):CD001084","journal-title":"Cochrane Database Syst Rev"},{"key":"CR20","first-page":"3","volume":"5","author":"Sakane","year":"2000","unstructured":"Sakane T, Takeno M (2000) Current therapy in Behcet?s disease. Skin Therapy Lett 5 (6):3?5","journal-title":"Skin Therapy Lett"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"404","DOI":"10.7326\/0003-4819-140-5-200403020-00025","volume":"140","author":"Sfikakis","year":"2004","unstructured":"Sfikakis PP, Kaklamanis PH, Elezoglou A et al. (2004) Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behcet disease. Ann Intern Med 140 (5):404?406","journal-title":"Ann Intern Med"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/0-306-48382-3_5","volume":"528","author":"Shahram","year":"2003","unstructured":"Shahram F, Davatchi F, Nadji A et al. (2003) Recent epidemiological data on Behcet?s disease in Iran. The 2001 survey. Adv Exp Med Biol 528:31?36","journal-title":"Adv Exp Med Biol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1023\/A:1022587012611","volume":"24","author":"Soylu","year":"2001","unstructured":"Soylu M, Demircan N, Pelit A (2001) Pars plana vitrectomy in ocular Behcet?s disease. Int Ophthalmol 24 (4):219?223","journal-title":"Int Ophthalmol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajo.2004.03.022","volume":"138","author":"Tugal-Tutkun","year":"2004","unstructured":"Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M (2004) Uveitis in Behcet disease: an analysis of 880 patients. Am J Ophthalmol 138 (3):373?380","journal-title":"Am J Ophthalmol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1076\/ocii.8.4.293.6453","volume":"8","author":"Wechsler","year":"2000","unstructured":"Wechsler B, Bodaghi B, Huong DL et al. (2000) Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behcet?s disease. Ocul Immunol Inflamm 8 (4):293?301","journal-title":"Ocul Immunol Inflamm"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2165\/00003495-199142050-00006","volume":"42","author":"Yazici","year":"1991","unstructured":"Yazici H, Barnes CG (1991) Practical treatment recommendations for pharmacotherapy of Behcet?s syndrome. Drugs 42 (5):796?804","journal-title":"Drugs"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000060761","volume":"31","author":"Yazici","year":"1999","unstructured":"Yazici H, Ozyazgan Y (1999) Medical management of Behcet?s syndrome. Dev Ophthalmol 31:118?131","journal-title":"Dev Ophthalmol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199002013220501","volume":"322","author":"Yazici","year":"1990","unstructured":"Yazici H, Pazarli H, Barnes CG et al. (1990) A controlled trial of azathioprine in Behcet?s syndrome. N Engl J Med 322 (5):281?285","journal-title":"N Engl J Med"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00002281-200401000-00008","volume":"16","author":"Yurdakul","year":"2004","unstructured":"Yurdakul S, Hamuryudan V, Yazici H (2004) Behcet syndrome. Curr Opin Rheumatol 16 (1):38?42","journal-title":"Curr Opin Rheumatol"},{"key":"CR30","first-page":"488","volume":"150","author":"Zouboulis","year":"1999","unstructured":"Zouboulis CC (1999) Epidemiology of Adamantiades-Behcet?s disease. Ann Med Interne (Paris) 150 (6):488?498","journal-title":"Ann Med Interne (Paris)"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/0-306-48382-3_2","volume":"528","author":"Zouboulis","year":"2003","unstructured":"Zouboulis CC, Keitel W (2003) A historical review of Adamantiades-Behcet?s disease. Adv Exp Med Biol 528:7?14","journal-title":"Adv Exp Med Biol"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/0-306-48382-3_33","volume":"528","author":"Zouboulis","year":"2003","unstructured":"Zouboulis CC, May T (2003) Pathogenesis of Adamantiades-Behcet?s disease. Adv Exp Med Biol 528:161?171","journal-title":"Adv Exp Med Biol"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1001\/archderm.134.8.1010","volume":"134","author":"Zouboulis","year":"1998","unstructured":"Zouboulis CC, Orfanos CE (1998) Treatment of Adamantiades-Behcet disease with systemic interferon alfa. Arch Dermatol 134 (8):1010?1016","journal-title":"Arch Dermatol"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/0-306-48382-3_7","volume":"528","author":"Zouboulis","year":"2003","unstructured":"Zouboulis CC, Kotter I, Djawari D et al. (2003) Current epidemiological data from the German Registry of Adamantiades-Behcet?s disease. Adv Exp Med Biol 528:43?48","journal-title":"Adv Exp Med Biol"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1523-1747.2003.12303.x","volume":"121","author":"Zouboulis","year":"2003","unstructured":"Zouboulis CC, Turnbull JR, Muhlradt PF (2003) High seroprevalence of anti-Mycoplasma fermentans antibodies in patients with malignant aphthosis. J Invest Dermatol 121 (1):211?212","journal-title":"J Invest Dermatol"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-004-1166-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-004-1166-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-004-1166-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:46:34Z","timestamp":1559036794000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-004-1166-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["1166"],"URL":"https:\/\/doi.org\/10.1007\/s00347-004-1166-2","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}